Navalign LLC’s Adient ADNT Stock Holding History

Navalign LLC’s Portfolio ADNT Stock Details ADNT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-125	Closed	-$2.4K	–	135
2025 Q4	$2.4K	Buy	+125	New	+$2.63K	﹤0.01%	421

Other funds holding ADNT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Pzena Investment Management New York $34.1B AUM 23.81% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Navalign LLC's ADNT Position: Q1 2026 in Review

Navalign LLC sold out of Adient (ADNT) in Q1 2026, closing a stake of 125 shares — an estimated $2.4K sold.

Navalign LLC first reported a position in ADNT in Q4 2025 and held it in 1 quarter. The position peaked at $2.4K in Q4 2025. 287 funds tracked by Wall St. Rank hold ADNT as of Q1 2026.

Navalign LLC reported no remaining Adient position as of Q1 2026 after selling out during the quarter.
Navalign LLC sold 125 Adient shares in Q1 2026, an estimated $2.4K.
Navalign LLC first reported a position in Adient in Q4 2025 and held it in 1 quarter.
Navalign LLC's Adient position peaked at $2.4K in Q4 2025.
287 funds tracked by Wall St. Rank held Adient as of Q1 2026.

Based on Navalign LLC's 13F filing for Q1 2026, filed 29 Apr 2026.